πŸ‡ΊπŸ‡Έ FDA
Patent

US 9303002

Compounds and their methods of use

granted A61PA61P35/00A61P37/00

Quick answer

US patent 9303002 (Compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00, A61P37/00